
### [NCIT:C27885](http://purl.obolibrary.org/obo/NCIT_C27885)
**Label:** Infiltrating Bladder Urothelial Carcinoma

**Subclasses:** [NCIT:C39819](http://purl.obolibrary.org/obo/NCIT_C39819) (Infiltrating Bladder Urothelial Carcinoma, Nested Variant), [NCIT:C39829](http://purl.obolibrary.org/obo/NCIT_C39829) (Infiltrating Bladder Urothelial Carcinoma with Giant Cells), [NCIT:C39818](http://purl.obolibrary.org/obo/NCIT_C39818) (Infiltrating Bladder Urothelial Carcinoma with Trophoblastic Differentiation), [NCIT:C8940](http://purl.obolibrary.org/obo/NCIT_C8940) (Stage III Bladder Urothelial Carcinoma), [NCIT:C8941](http://purl.obolibrary.org/obo/NCIT_C8941) (Stage IV Bladder Urothelial Carcinoma), [NCIT:C6191](http://purl.obolibrary.org/obo/NCIT_C6191) (Stage I Bladder Urothelial Carcinoma), [NCIT:C39820](http://purl.obolibrary.org/obo/NCIT_C39820) (Infiltrating Bladder Urothelial Carcinoma, Microcystic Variant), [NCIT:C39826](http://purl.obolibrary.org/obo/NCIT_C39826) (Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant without Heterologous Elements), [NCIT:C39825](http://purl.obolibrary.org/obo/NCIT_C39825) (Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant with Heterologous Elements), [NCIT:C39817](http://purl.obolibrary.org/obo/NCIT_C39817) (Infiltrating Bladder Urothelial Carcinoma with Glandular Differentiation), [NCIT:C39816](http://purl.obolibrary.org/obo/NCIT_C39816) (Infiltrating Bladder Urothelial Carcinoma with Squamous Differentiation), [NCIT:C39821](http://purl.obolibrary.org/obo/NCIT_C39821) (Infiltrating Bladder Lymphoepithelioma-Like Carcinoma), [NCIT:C8939](http://purl.obolibrary.org/obo/NCIT_C8939) (Stage II Bladder Urothelial Carcinoma), [NCIT:C39824](http://purl.obolibrary.org/obo/NCIT_C39824) (Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant), 

**Class expressions from DL-Learner:**

- Thing 55.02%
- [NCIT:C41454](http://purl.obolibrary.org/obo/NCIT_C41454) (Cystic Change) 53.95%
- [NCIT:C54560](http://purl.obolibrary.org/obo/NCIT_C54560) (Human Chorionic Gonadotropin Positive Neoplastic Cells Present) 51.32%
- [NCIT:C54559](http://purl.obolibrary.org/obo/NCIT_C54559) (Heterologous Elements Present) 51.32%
- [NCIT:C41464](http://purl.obolibrary.org/obo/NCIT_C41464) (Macrocystic Change) 51.32%
- [NCIT:C41456](http://purl.obolibrary.org/obo/NCIT_C41456) (Microcystic Change) 51.32%
- [NCIT:C39875](http://purl.obolibrary.org/obo/NCIT_C39875) (Loss of Chromosome 9q) 51.32%
- [NCIT:C39716](http://purl.obolibrary.org/obo/NCIT_C39716) (EGFR Protein Overexpression) 51.32%
- [NCIT:C38770](http://purl.obolibrary.org/obo/NCIT_C38770) (Squamous Differentiation) 51.32%
- [NCIT:C36681](http://purl.obolibrary.org/obo/NCIT_C36681) (MDM2 Gene Amplification) 51.32%
- [NCIT:C36679](http://purl.obolibrary.org/obo/NCIT_C36679) (HRAS Gene Amplification) 51.32%
- [NCIT:C36652](http://purl.obolibrary.org/obo/NCIT_C36652) (CCND1 Gene Amplification) 51.32%
- [NCIT:C36649](http://purl.obolibrary.org/obo/NCIT_C36649) (EGFR Gene Amplification) 51.32%
- [NCIT:C36639](http://purl.obolibrary.org/obo/NCIT_C36639) (ERBB2 Protein Overexpression) 51.32%
- [NCIT:C36638](http://purl.obolibrary.org/obo/NCIT_C36638) (ERBB2 Gene Amplification) 51.32%


